النتائج (
الإنجليزية) 3:
[نسخ]نسخ!
"The public health burden of prostate cancer. The total of 220,800 new cases of prostate cancer, 27,540 deaths from the disease in the United States by 2015, making it the most common Nwndyrmatwlwjyk cancer among men in the United States. A man of prostate cancer risk is one in seven.Prostate cancer is the second leading cause of death of cancer in men, only lung cancer surpassed.
remain asymptomatic men with prostate cancer die from causes other than related and not due to cancer.This may be due to advanced age, many men at the time of diagnosis, slow tumor growth, and response to treatment.The estimated number of men with prostate cancer morbidity (i.e., prostate cancer, which is present in the prostate gland but never disclose or diagnosed during the lifetime of the patient. The number of men with MS diagnosed clinically.It is necessary to understand the biological and genetic mechanisms that determine why some prostate cancers remain clinically silent, while others cause serious disease, and even life-threatening. "Prostate cancer and exhibits considerable variations in incidence among populations all over the world; the proportion of countries with high and low incidence of prostate cancer is provided to 100-fold.Usually Asian men only a very low proportion of prostate cancer, with age standardized prevalence rates ranging from 2 to 10 cases per 100,000 men. The highest incidence rates generally in the Nordic countries.However, men, African Americans, the highest incidence rate of prostate cancer in the world. In the United States, American men of African descent have a rate of the highest 60% than white men.The men of African Americans to be approximately twice the death rate, particularly prostate cancer than white men are not of Spanish origin.A narrowing of differences in prostate cancer survival estimates for race against time. "These differences may be the result of the interaction of genetic and environmental influences (such as access to social and health care), which may influence the development and evolution of the disease.The differences in screening practices also had a great influence on the incidence of prostate cancer, allowing for prostate cancer diagnosis, some patients before the development of symptoms or abnormalities. Physically detectable.Analysis of population-based data from Sweden, he suggested that the diagnosis of prostate cancer and one brother, lead to early diagnosis in the second sibling screening using prostate antigen (PSA).This may represent an increase in prostate cancer diagnosed in younger men was evident in the data for incidence at the national level.The genetic contribution to the risk of prostate cancer, an increased knowledge of the molecular genetics of disease have been documented, although much of what is known is not clinically feasible.The transformation of malignant prostate epithelial cells and prostate cancer may result from a complex series of promotional events and initiate under both genetic and environmental influences.
يجري ترجمتها، يرجى الانتظار ..